Study to Assess the Reliability of PASI Scoring Using Digital-Based Images
NCT05835843 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 34
Last updated 2025-09-12
Summary
This is an open-labeled study to evaluate the reliability of digital photographs for the remote assessment of the disease severity of plaque psoriasis.
Conditions
Interventions
- OTHER
-
In-Person and Remote Disease Assessment
Disease severity will be assessed during the in-person visit and standardized digital photographs of different body regions and/or the full body will be collected for remote evaluations by external dermatologists.
Sponsors & Collaborators
-
Innovaderm Research Inc.
lead OTHER
Principal Investigators
-
Robert Bissonnette, MD · Innovaderm Research Inc.
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-06-02
- Primary Completion
- 2024-07-09
- Completion
- 2025-09-05
Countries
- Canada
Study Locations
More Related Trials
-
Assessing the Long Term Effectiveness and Safety of Biotherapies in the Treatment of Cutaneous Psoriasis
NCT01617018 ·Status: COMPLETED
-
IL-17 Role in Variants of Psoriasis
NCT02078297 ·Status: COMPLETED
-
An Observational Study to Evaluate Patient-Reported Experiences of Living With Moderate-to-Severe Plaque Psoriasis
NCT01555606 ·Status: COMPLETED
-
Premature Coronary Artery Disease (CAD) in Severe Psoriasis
NCT00893126 ·Status: COMPLETED
-
Assessing the Long Term Effectiveness and Safety of Systemic Treatments in Cutaneous Psoriasis
NCT04841187 ·Status: COMPLETED
-
Modifying PEST for Psoriatic Arthritis Screening
NCT06382051 ·Status: RECRUITING ·Phase: NA
-
PASIMAT: Automatic Measure of PASI
NCT02808559 ·Status: COMPLETED ·Phase: NA
-
Clinical and Molecular Characterization of Axial Psoriatic Arthritis (PsA), A Pilot Study
NCT05925842 ·Status: UNKNOWN
-
A 24-week, Multicenter, proSpective stUdy to Evaluate the PASI 90 Clinical Response Rate and the Safety PRofile of sEcukinuMab 300 mg in Cw6-negativE and Cw6-positive Patients With Moderate to Severe Chronic Plaque-type Psoriasis (SUPREME)
NCT02394561 ·Status: COMPLETED ·Phase: PHASE3
-
Etanercept Therapy for Nails Psoriasis Monitoring With Noninvasive Imaging
NCT05135312 ·Status: UNKNOWN ·Phase: PHASE4
-
The Study of Koebner in Patients With Psoriasis and Psoriatic Arthritis
NCT05589298 ·Status: COMPLETED
-
A Dose Finding Study of AEB071 Assessing Psoriasis Area and Severity Index in Patients With Plaque Psoriasis
NCT00885196 ·Status: COMPLETED ·Phase: PHASE2
-
Long-Term Safety of IDP-118 Lotion in the Treatment of Plaque Psoriasis
NCT02462083 ·Status: COMPLETED ·Phase: PHASE3
-
The Immunological Basis for Treatment Resistance to Anti-TNF Treatments
NCT01971346 ·Status: COMPLETED ·Phase: PHASE4
-
A Observational Study to Evaluate Deucravacitinib in Patients With Moderate Plaque Psoriasis in China
NCT06512337 ·Status: ACTIVE_NOT_RECRUITING
-
A Study to Evaluate Effectiveness and Safety of BMS-986322 in Participants With Moderate-to-Severe Psoriasis
NCT05730725 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Benefit and Safety of GSK2982772 in Moderate to Severe Psoriasis Participants
NCT04316585 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase II Study of MEDI-507, Administered by Injection to Adults With Psoriasis
NCT00540618 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Namilumab (MT203) for Plaque Psoriasis
NCT02129777 ·Status: COMPLETED ·Phase: PHASE2
-
Serum Level of Bioactive Mediators and Urinary Biopyrins in Psoriasis
NCT03889938 ·Status: UNKNOWN
-
Cytokines and Vascular Inflammation in Psoriasis
NCT02305953 ·Status: COMPLETED
-
An Explorative Psoriasis Biomarker Study
NCT04394936 ·Status: TERMINATED ·Phase: NA
-
A Study to Evaluate the Efficacy and Safety of Mirikizumab (LY3074828) in Participants With Moderate-to-Severe Plaque Psoriasis
NCT03482011 ·Status: COMPLETED ·Phase: PHASE3
-
Cytokine Expression in Psoriasis Patients with and Without Joint Involvement
NCT05307809 ·Status: RECRUITING ·Phase: NA
-
Photographic Library of Moderate to Severe Psoriasis Subjects Treated With Infliximab (Study P05047)
NCT00749398 ·Status: COMPLETED